Bill
S 2655
Requires health plans to cover diagnosis and treatment of pediatric acute-onset neuropsychiatric syndrome (PANS), boosting access for affected children and guiding insurers.
Status snapshot
- Bill number: S 2655 (2025)
- Title: Relates to insurance coverage for pediatric acute‑onset neuropsychiatric syndrome (PANS)
- Introduced: August 1, 2025
- Current referral/action: Referred to Committee on Insurance (also had earlier referral to Judiciary and extensive Senate amendment activity; see timeline below)
- Sponsors (as listed): Dan Stec (primary), Richard Blumenthal (cosponsor), Patrick M. Gallivan, Joseph A. Griffo, Peter Oberacker
- Related/previous session bills: S 7256, S 1994, S 5332, S 3038
Note on provided materials
- The full text excerpt supplied in the request is a Senate document (S.2655) that appears primarily to be an FY2025 supplemental appropriations/omnibus amendment from the Massachusetts General Court and contains numerous appropriation items. That appropriations text does not contain explicit policy language on insurance coverage for PANS.
- The bill title and the metadata you provided indicate the substantive subject is insurance coverage for pediatric acute‑onset neuropsychiatric syndrome (PANS). Because the concrete policy language is not included in the supplied text, the summary below (a) describes the bill’s stated purpose and likely scope based on the title and typical practice, and (b) flags the discrepancy and recommends consulting the official bill text or committee report for exact provisions.
Purpose and intent
- At a high level, S.2655 is intended to address insurance coverage for pediatric acute‑onset neuropsychiatric syndrome (PANS), a clinical syndrome characterized by sudden onset of OCD-like and/or food‑restriction behaviors and other neuropsychiatric symptoms in children. The stated goal is to ensure that health insurers cover diagnosis and treatment services related to PANS so affected children can access appropriate care.
Likely key topics such a bill would address (verify in the official text)
- Definitions: a statutory definition of PANS/PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections) and what constitutes a covered diagnosis/treatment.
- Covered services: mandate that group and individual health plans (and possibly Medicaid / state plans) cover medically necessary services for PANS, potentially including diagnostic testing, medical treatments (e.g., antibiotics, immunomodulatory therapy if clinically indicated), psychiatric care, psychotherapy, and occupational/educational supports.
- Parity and prior authorization: limits on denials, prior‑authorization procedures, grounds for medical necessity determinations, and appeal rights.
- Provider scope and credentialing: which clinicians may diagnose/treat and billing/coverage rules.
- Effective dates and applicability: which types of plans are covered (commercial, small group, state plans) and when the mandate takes effect.
Who would be affected
- Primary: children diagnosed with PANS and their families — increased access to reimbursed diagnosis and treatment.
- Insurers: private health carriers, third‑party administrators, and possibly the state Medicaid program — potential increases in covered service utilization and costs.
- Health care providers: pediatricians, child psychiatrists, neurologists, immunologists, therapists — may see increased demand and reimbursement coverage for services related to PANS.
- State budget: if the mandate applies to state programs (e.g., Medicaid), there may be fiscal implications; appropriation text in the supplied document does not specify funding linked to this policy.
Legislative timeline and activity (selected)
- 2025-08-01: Introduced in Senate; read twice and referred to Judiciary.
- 2025-01-22: (also listed) Referred to Insurance — current referral reported as “REFERRED TO INSURANCE.”
- 2025-10-20 to 2025-10-23: Extensive Senate Ways & Means activity and numerous amendments to a Senate substitute text (many amendments adopted and rejected; the substitute was reprinted as S.2670 and substituted for H.4615). These entries appear tied to the appropriations/substitute text in the provided document rather than to a standalone insurance mandate.
Potential impacts and considerations
- Access: If enacted as a coverage mandate, the bill could improve timely access to multidisciplinary care for children with PANS.
- Cost: Mandating coverage for additional diagnostic or treatment services may increase insurer costs and, depending on design (and whether state programs are covered), could affect premiums or state Medicaid expenditures.
- Implementation: Much depends on precise definitions, covered services, prior‑authorization limits, and whether state programs receive accompanying funding or regulatory guidance.
Recommendation
- Because the supplied bill text is an appropriations substitute and does not include clear policy language on PANS coverage, review the official bill text posted by the legislature (or the latest committee substitute/report) to confirm the specific mandates, definitions, affected plan types, exemptions, effective dates, and any fiscal notes. Contact the committee staff for the Insurance Committee for the most current draft and fiscal impact analysis.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
